New biomarkers in rheumatoid arthritis

Related Experiment Video

Updated: May 17, 2026

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice
07:37

An Adoptive Transfer Model of Rheumatoid Arthritis in Mice

Published on: June 6, 2025

A Willemze1, R E M Toes, T W J Huizinga

  • 1Department of Rheumatology, Leiden University Medical Center, Leiden, the Netherlands. a.willemze@lumc.nl

The Netherlands Journal of Medicine
|November 6, 2012
PubMed

Insights

New biomarkers for rheumatoid arthritis (RA) show promise. Anti-carbamylated protein antibodies (anti-CarP) aid in diagnosing ACPA-negative RA and predicting joint damage, improving early RA management.

Area of Science:

  • Immunology
  • Rheumatology
  • Autoimmune Diseases

Background:

  • Rheumatoid arthritis (RA) affects 1% of the population, with early intervention crucial for best outcomes.
  • Accurate diagnosis and prognosis in early RA, especially before fulfilling diagnostic criteria, remain challenging.
  • Existing biomarkers like rheumatoid factor (RF) and anti-citrullinated protein antibodies (ACPA) are valuable but not exhaustive.

Purpose of the Study:

  • To explore novel biomarkers for improved rheumatoid arthritis (RA) diagnosis and management.
  • To investigate the role of anti-carbamylated protein antibodies (anti-CarP) in RA pathogenesis and prognosis.
  • To highlight the potential of biomarker-based scores for monitoring disease activity.

Main Methods:

  • Review of recent advancements in RA biomarker research.
  • Analysis of the presence and significance of anti-carbamylated protein antibodies (anti-CarP) in RA patients.
  • Discussion of emerging biomarkers reflecting clinical disease activity.

Main Results:

  • Anti-carbamylated protein antibodies (anti-CarP) are present in approximately 20% of ACPA-negative RA patients.
  • Anti-CarP antibodies are associated with more severe joint damage in ACPA-negative RA.
  • Novel biomarkers are being identified that correlate with clinical disease activity scores.

Conclusions:

  • Anti-CarP antibodies represent a significant diagnostic and prognostic tool, particularly for ACPA-negative RA.
  • Biomarker discovery is advancing the understanding of RA pathogenesis and aetiology.
  • Development of biomarker-based disease activity scores could enable frequent patient monitoring and personalized treatment adjustments.

More Related Videos

Automated Joint Space Detection Improves Bone Segmentation Accuracy06:45

Automated Joint Space Detection Improves Bone Segmentation Accuracy

Published on: November 28, 2025

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies01:22

Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies

The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...